Esther12
Senior Member
- Messages
- 13,774
$1 Million seems very excessive
Wasn't the $1 million just speculative anyway? Details on cost still have not been released.
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
$1 Million seems very excessive
Yes, you're right. I tried to find out what the budget and breakdown of it was for the last GWI report from IOM, but couldn't find anything. All I could find was a third-party's listing of the costs of the nine IOM GWI reports through August 1, 2002. According to this site, at least, there were nine reports costing an average of $1,826,000 each.Wasn't the $1 million just speculative anyway? Details on cost still have not been released.
Please forward to CAA Board of Directors
Please cc to CAA Officers and Public Relations/Outreach Director
Members of the Board:
Let me first express my appreciation for the apparent strides CAA has made in the last year or so. In my eyes, these include steps like removing the CDC toolkit and other misinformation from your website, your increased focus on an apparently (to my mind, which has quite limited scientific literacy) well-thought out research plan, the use of "ME" in ME/CFS, increased communication with patients, the inclusion of PEM/PER/PENE as a requirement for contributions to your biological sample bank, the installation of a new CEO, and perhaps other initiatives of which I am unaware.
In my strong and well-considered view, there is still great improvement to be made. I am writing you now because of your expressed support of the contract between HHS and IOM for a new clinical case definition for ME. A few months ago, many organizations and patients signed a petition to HHS to change the name of the disease back to ME and to immediately adopt the CCC. More recently, a great number of patients have contacted HHS and Congress to demand that the CCC be immediately adopted and that the IOM contract not be signed (and now cancelled). As you know 35 (now 34) of the very top ME researchers and clinicians in the world wrote to HHS demanding the same thing- no IOM contract and immediate adoption of CCC.
You are well familiar with the reasons for these demands (If you wish to be reminded, I simply refer you to the letter by the 35, now 34 experts). You stand virtually alone among stakeholders in your approval of the IOM contract. I now strongly request that you change your stance for the good of the whole community.
A year or two ago, in response to a deluge of criticism by patient activists/experts, CAA announces that it was now focused as a "laser" on research and was no longer a patient advocacy organization. I strongly object to your coming out now into the public arena as a supposed patient advocate, by doing such things as stating your support for the IOM contract, contacting the 35 signatories to subtly influence them to change their views, and it seems, responding to members of congress and the press as a patient organization.
The announcement by HHS of the IOM contract did very little to address the concerns of patients, clinicians and researchers, despite your claims and those of HHS to the contrary. The contract is at fundamental odds with the request for a stakeholder definition meeting by CFSAC and will be loaded with non-experts who will almost certainly screw things up royally (especially apparent in light of IOM's recent Gulf War Illness report). Please reconsider your position, I beg you, for the good of everyone.
I very much welcome contact from any or all of the board for friendly discussion. In any event, I look forward to a timely response. Thank you for your consideration.
Sincerely,
/s/
Justin Reilly, esq.
Excellent. The pressure must be continuous until they relent. Add the board of directors of Pandora and Offer (Bateman) in Utah as well. Critical Mass is needed from everyone to get their attention!I wrote to CAA's board:
Ecoclimber - And I remember something like 6-8 months ago a new NIH grant of $500-800,000 was given to Friedberg to study coping with fatigue.
Time flies. We discussed that $600,000 NIH grant here two years ago. Dr. Friedberg's study reports huge dropout rates, by the way: “Dropout rates at the 12-month follow-up were high (42%-53%), perhaps attributable to the burden of monthly telephone calls to assess health care use.”Ecoclimber - And I remember something like 6-8 months ago a new NIH grant of $500-800,000 was given to Friedberg to study coping with fatigue.
Okay I know this is sort of OT but for cryin' out loud we are *all* fricking experts on coping, and with a lot more than fatigue!! I am so over this crap!! Someone should give *us* all that money for having already coped for decades now!
Oops, wow, time does fly!Time flies. We discussed that $600,000 NIH grant here two years ago. Dr. Friedberg's study reports huge dropout rates, by the way: “Dropout rates at the 12-month follow-up were high (42%-53%), perhaps attributable to the burden of monthly telephone calls to assess health care use.”:thumbdown:
This was posted by Wildaisy on mecfsforum:
This is Dr. Mikovtz' response to CAA's letter to the 35.
Yes they did and below is the response I sent:To whom it may concern:I absolutely stand by my work of the last 7 years including my signature on the letter to secretary Sebelius of 9/23 regarding the case definition of ME/CFS.I know that the CAA is not and has never in my experience responded to concerns expressed by the patients nor do they now or have they ever served in the best interests of the patients as is the only duty of an advocacy organization. This IOM contract is simply a waste of precious resources.
I stand by my signature on the letter and my work which is now always has been and will always be in the best interests of the patients.Sincerely,Judy A Mikovits, PhD
Reply #16
I have contacted as many of the people who signed the Open Letter to Dr. Sebelius as I was able to, and I have gotten some answers. Some people were not contacted by the CAA. Some were contacted and refused to withdraw their support from the CCC. If I receive permission, I'll post their responses.
It is absolutely clear to me from what they have told me that the CAA was, indeed, attempting to get these signers to withdraw their support from the CCC and to support the CAA in its support for the IOM contract.
As the conversation concerning the HHS/IOM contract continues, many advocates are weighing in. Over the past several days we’ve received several questions about various points in the discussion so we wanted to address them.
First, I sent an email to my colleagues who signed the letter to Secretary Sebelius asking to adopt the Canadian Consensus Criteria and cancel the IOM contract. There is speculation that I asked them to rescind their signature. I did not ask anyone to rescind their signature or change their mind. I reached out to those I had email addresses for (29 signatories), asking if they still agreed with the letter given the IOM contract was awarded and more information on the scope of work had been provided. I heard from about half of the signatories. Several stood by their signature indicating the money for the contract should go to research. Others didn’t feel an IOM committee would do a good job. And yet others were hopeful that the IOM contract would be productive and effective. It was important to hear this because we value their expertise and opinions. Many look to us for insight, opinion and information. We try to understand all sides of an issue so we can provide the most balanced information and make the most informed decisions.
Many of my fellow advocates have asked if I am benefiting financially from my participation on the IOM committee for development of a case definition for chronic multisymptom illness. I am not. Committee member air travel and lodging are paid for with the IOM contract – which was awarded to the IOM by the Veterans Administration. Committee members receive a per diem to cover costs incurred during travel, but all work is voluntary. Outside of the meetings we have a lot of reading and research to do to accomplish our charge. Like in ME/CFS, there has been outstanding work and research on Gulf War Illness and there are significant gaps in knowledge. No one on the committee takes this responsibility lightly. We have 3 more months and two more committee meetings to complete our tasks.
Several individuals have speculated that I am on this committee purely because my brother has Gulf War Illness (my brother is happy that I was nominated and he is hopeful for our outcome), but that is not why. I was nominated for the committee because of my work and research on ME/CFS. My brother relates to ME/CFS patients because as he and many of you know, Gulf War Illness and ME/CFS have many clinical similarities. For those of you that haven’t yet, please read his personal story: http://www.cfids.org/cfidslink/2010/020304.asp [1]
Some that are deeply opposed to the IOM contract to develop a clinical case definition for ME/CFS do not understand why we are in the discussion if we are an organization focused on research. It is precisely because we are focused on research that case definition is important to us. A physician or healthcare provider can only diagnose ME/CFS after thorough clinical evaluation. It is critically important that this clinical approach to diagnosing ME/CFS be defined and standardized for use by all physicians and providers. The diagnostic criteria is essential to advance research because it provides us with the disease-defining concepts – the core signs and symptoms – needed to identify and validate biomarkers and to provide evidence of treatment benefit.
While we understand the concerns over the contract with the IOM: fears that the right people will not be on the committee, leading to a lack of commitment and faulty results, we believe it is in the patients best interest to continue to foster a positive working relationship with HHS and IOM. No single organization can solve ME/CFS on its own. We must have the cooperation and involvement of the various federal agencies to increase research funding and achieve real progress. We can only do that if we are at the table.
We all have a lot of urgent work to do and we all can continue to contribute and help our community. There is plenty of work that needs to be done – more than enough to go around. We must galvanize around ME/CFS in order to conquer it.
Framing that argument are these statements that may be difficult to reconcile:Some that are deeply opposed to the IOM contract to develop a clinical case definition for ME/CFS do not understand why we are in the discussion if we are an organization focused on research. It is precisely because we are focused on research that case definition is important to us....The diagnostic criteria is essential to advance research because it provides us with the disease-defining concepts – the core signs and symptoms – needed to identify and validate biomarkers and to provide evidence of treatment benefit (emphasis added).”
It is critically important that this clinical approach to diagnosing ME/CFS be defined and standardized for use by all physicians and providers. The diagnostic criteria is essential to advance research because it provides us with the disease-defining concepts – the core signs and symptoms – needed to identify and validate biomarkers and to provide evidence of treatment benefit.
There is speculation that I asked them to rescind their signature. I did not ask anyone to rescind their signature or change their mind. I reached out to those I had email addresses for (29 signatories), asking if they still agreed with the letter given the IOM contract was awarded and more information on the scope of work had been provided. I heard from about half of the signatories.
I reached out to those I had email addresses for (29 signatories), asking if they still agreed with the letter given the IOM contract was awarded and more information on the scope of work had been provided.
There is speculation that I asked them to rescind their signature. I did not ask anyone to rescind their signature or change their mind. I reached out to those I had email addresses for (29 signatories), asking if they still agreed with the letter given the IOM contract was awarded and more information on the scope of work had been provided. I heard from about half of the signatories. Several stood by their signature indicating the money for the contract should go to research. Others didn’t feel an IOM committee would do a good job. And yet others were hopeful that the IOM contract would be productive and effective. It was important to hear this because we value their expertise and opinions. Many look to us for insight, opinion and information. We try to understand all sides of an issue so we can provide the most balanced information and make the most informed decisions.
Some that are deeply opposed to the IOM contract to develop a clinical case definition for ME/CFS do not understand why we are in the discussion if we are an organization focused on research. It is preciselybecause we are focused on research that case definition is important to us.
A physician or healthcare provider can only diagnose ME/CFS after thorough clinical evaluation. It is critically important that this clinical approach to diagnosing ME/CFS be defined and standardized for use by all physicians and providers.
While we understand the concerns over the contract with the IOM: fears that the right people will not be on the committee, leading to a lack of commitment and faulty results, we believe it is in the patients best interest to continue to foster a positive working relationship with HHS and IOM.
The Clearing the Air argument is made in support of the IOM contract, designed to develop a “clinical case definition and a clear distinction from case definitions for clinical trials and research.” Yet the argument slips from discussing a “clinical case definition” to a "case definition” to advancing research "needed to identify and validate biomarkers and to provide evidence of treatment benefit:”
Framing that argument are these statements that may be difficult to reconcile:
“I heard from about half of the signatories.... We try to understand all sides of an issue so we can provide the most balanced information and make the most informed decisions;”
“We must have the cooperation and involvement of the various federal agencies to increase research funding and achieve real progress. We can only do that if we are at the table (emphasis added).”
Who is this "we?" Cynically, their statement would have made more sense to me had it read, “[CFIDS Association of America] must have the cooperation and involvement of the various federal agencies to increase [its] research funding.... We can only do that if we are at the table.”
I have to add here that I think (my personal opinion) that the CAA is really overstating their possible influence with this IOM contract. IOM was supposedly picked because they are an independent, non-government, non-profit organization. They pride themselves on their independent actions. If they do accept any influence by any patient group, government branch or any political or social organization, their independent statures will come in to question and they can't afford that.
From the moment that this contract was signed, it is on track to be dealt with the exact same way as the GWI contract. This is the way of IOM studies. We are not going to change that. It's like a train, once it's on a track, it will follow that track. If it sways, it will derail.